Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Endocrinology
Volume 2013 (2013), Article ID 174593, 4 pages
http://dx.doi.org/10.1155/2013/174593
Case Report

Acanthosis Nigricans Associated with an Adrenocortical Tumor in a Pediatric Patient

1Department of Pediatrics, The Children's Hospital of Philadelphia, 34th Street and Civic Center Boulevard, 3535 Market Street, Room 1562, Philadelphia, PA 19104, USA
2Division of Pediatric Endocrinology, St. Christopher's Hospital for Children, 3601 A. Street, Philadelphia, PA 19134, USA
3Division of Pediatric Endocrinology, Monmouth Medical Children's Hospital, 180 Avenue at the Commons, Suite 7B, Shrewsbury, NJ 07702, USA
4Department of Pathology, The Children's Hospital of Philadelphia, 34th Street and Civic Center Boulevard, Philadelphia, PA 19104, USA
5Department of General Surgery, The Children's Hospital of Philadelphia, 34th Street and Civic Center Boulevard, Philadelphia, PA 19104, USA

Received 13 March 2013; Accepted 19 May 2013

Academic Editors: C. Capella, M. Demura, N. Islam, and M. P. Kane

Copyright © 2013 Elizabeth Isaacoff et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. C. Ribeiro, R. S. Neto, M. J. Schell, L. Lacerda, G. A. Sambaio, and I. Cat, “Adrenocortical carcinoma in children: a study of 40 cases,” Journal of Clinical Oncology, vol. 8, no. 1, pp. 67–74, 1990. View at Google Scholar · View at Scopus
  2. J. A. Wieneke, L. D. R. Thompson, and C. S. Heffess, “Adrenal cortical neoplasms in the pediatric population: a clinicopathologic and immunophenotypic analysis of 83 patients,” The American Journal of Surgical Pathology, vol. 27, no. 7, pp. 867–881, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. R. Sandrini, R. C. Ribeiro, and L. DeLacerda, “Extensive personal experience: childhood adrenocortical tumors,” Journal of Clinical Endocrinology and Metabolism, vol. 82, no. 7, pp. 2027–2031, 1997. View at Publisher · View at Google Scholar · View at Scopus
  4. E. Michalkiewicz, R. Sandrini, B. Figueiredo et al., “Clinical and outcome characteristics of children with adrenocortical tumors: a report from the international pediatric adrenocortical tumor registry,” Journal of Clinical Oncology, vol. 22, no. 5, pp. 838–845, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. A. O. Ciftci, M. E. Şenocak, F. C. Tanyel, and N. Büyükpamukçu, “Adrenocortical tumors in children,” Journal of Pediatric Surgery, vol. 36, no. 4, pp. 549–554, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. C. Rodriguez-Galindo, B. C. Figueiredo, G. P. Zambetti, and R. C. Ribeiro, “Biology, clinical characteristics, and management of adrenocortical tumors in children,” Pediatric Blood and Cancer, vol. 45, no. 3, pp. 265–273, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. R. L. Moore and T. S. Devere, “Epidermal manifestations of internal malignancy,” Dermatologic Clinics, vol. 26, no. 1, pp. 17–29, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. H. Curth, “Cancer associated with acanthosis nigricans: review of literature and report of a case of acanthosis nigricans with cancer of the breast,” Archives of Surgery, vol. 47, no. 6, pp. 517–552, 1943. View at Publisher · View at Google Scholar
  9. M. Ramos-e-Silva, J. C. Carvalho, and S. C. Carneiro, “Cutaneous paraneoplasia,” Clinics in Dermatology, vol. 29, no. 5, pp. 541–547, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. M. D. Wooten and D. K. King, “Adrenal cortical carcinoma. Epidemiology and treatment with mitotane and a review of the literature,” Cancer, vol. 72, no. 11, pp. 3145–3155, 1993. View at Publisher · View at Google Scholar
  11. L. Bernstein and J. G. Gurney, “Carcinomas and other malignant epithelial neoplasms,” in Cancer Incidence and Survival Among Children and Adolescents: United States SEER Program 1975–1995, pp. 139–148, National Cancer Institute, Bethesda, Md, USA, 1999. View at Google Scholar
  12. S. Boyce and J. Harper, “Paraneoplastic dermatoses,” Dermatologic Clinics, vol. 20, no. 3, pp. 523–532, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. H. O. Sedano and R. J. Gorlin, “Acanthosis nigricans,” Oral Surgery Oral Medicine and Oral Pathology, vol. 63, no. 4, pp. 642–467, 1987. View at Google Scholar · View at Scopus
  14. P. Bhargava, S. Bhargava, D. Mathur, U. S. Agarwal, and R. Bhargava, “Malignant acanthosis nigricans in a 2 year old child with Wilm's tumour,” Indian Journal of Dermatology, Venereology and Leprology, vol. 64, no. 1, pp. 29–30, 1998. View at Google Scholar
  15. T. C. Garrott, “Malignant acanthosis nigricans associated with osteogenic sarcoma,” Archives of Dermatology, vol. 106, no. 3, pp. 384–385, 1972. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Hiranandani, I. Kaur, S. C. Singhi, and U. Bhoria, “Malignant acanthosis nigricans in adrenal carcinoma,” Indian pediatrics, vol. 32, no. 8, pp. 920–923, 1995. View at Google Scholar · View at Scopus
  17. D. L. Ellis, S. P. Kafka, J. C. Chow et al., “Melanoma, growth factors, acanthosis nigricans, the sign of leser-trelat, and multiple acrochordons. A possible role for alpha-transforming growth factor in cutaneous paraneoplastic syndromes,” The New England Journal of Medicine, vol. 317, no. 25, pp. 1582–1587, 1987. View at Google Scholar · View at Scopus
  18. G. A. Meyers, S. J. Orlow, I. R. Munro, K. A. Przylepa, and E. W. Jabs, “Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigricans,” Nature Genetics, vol. 11, no. 4, pp. 462–464, 1995. View at Google Scholar · View at Scopus
  19. P. L. Tavormina, G. A. Bellus, M. K. Webster et al., “A novel skeletal dysplasia with developmental delay and acanthosis nigricans is caused by a Lys650Met mutation in the fibroblast growth factor receptor 3 gene,” The American Journal of Human Genetics, vol. 64, no. 3, pp. 722–731, 1999. View at Publisher · View at Google Scholar · View at Scopus
  20. L. Castro-Feijóo, L. Loidi, A. Vidal et al., “Hypochondroplasia and acanthosis nigricans: a new syndrome due to the p.Lys650Thr mutation in the fibroblast growth factor receptor 3 gene?” European Journal of Endocrinology, vol. 159, no. 3, pp. 243–249, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. D. R. Berk, E. B. Spector, and S. J. Bayliss, “Familial acanthosis nigricans due to K650T FGFR3 mutation,” Archives of Dermatology, vol. 143, no. 9, pp. 1153–1156, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. Hida, Y. Kubo, Y. Nishio et al., “Malignant acanthosis nigricans with enhanced expression of fibroblast growth factor receptor 3,” Acta Dermato-Venereologica, vol. 89, no. 4, pp. 435–437, 2009. View at Publisher · View at Google Scholar · View at Scopus